by Elena Iemma | May 17, 2021 | News
PROVIDENCE, RI, May 17, 2021 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) announces the publication “Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation” in NPJ Vaccines. This research identifies...
by Annie De Groot | May 1, 2020 | Events, Webinars
This webinar has passed but we invite you to view the recording below. Please extend this invitation to any colleagues or associates you feel would benefit from attending. Participation is always free and open to all. We look forward to “seeing” you...
